NO981822D0 - Anvendelse av proteinet GAX for behandling av cancer - Google Patents

Anvendelse av proteinet GAX for behandling av cancer

Info

Publication number
NO981822D0
NO981822D0 NO981822A NO981822A NO981822D0 NO 981822 D0 NO981822 D0 NO 981822D0 NO 981822 A NO981822 A NO 981822A NO 981822 A NO981822 A NO 981822A NO 981822 D0 NO981822 D0 NO 981822D0
Authority
NO
Norway
Prior art keywords
cancer
treatment
gax protein
gax
protein
Prior art date
Application number
NO981822A
Other languages
English (en)
Norwegian (no)
Other versions
NO981822L (no
Inventor
Aude Leroux
Didier Branellec
Patrice Denefle
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of NO981822D0 publication Critical patent/NO981822D0/no
Publication of NO981822L publication Critical patent/NO981822L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/10—Vectors comprising a non-peptidic targeting moiety
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/40—Vectors comprising a peptide as targeting moiety, e.g. a synthetic peptide, from undefined source

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO981822A 1995-10-31 1998-04-23 Anvendelse av proteinet GAX for behandling av cancer NO981822L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9512871A FR2740344B1 (fr) 1995-10-31 1995-10-31 Application de la proteine gax au traitement de cancers
PCT/FR1996/001690 WO1997016459A1 (fr) 1995-10-31 1996-10-28 Application de la proteine gax au traitement de cancers

Publications (2)

Publication Number Publication Date
NO981822D0 true NO981822D0 (no) 1998-04-23
NO981822L NO981822L (no) 1998-04-23

Family

ID=9484112

Family Applications (1)

Application Number Title Priority Date Filing Date
NO981822A NO981822L (no) 1995-10-31 1998-04-23 Anvendelse av proteinet GAX for behandling av cancer

Country Status (13)

Country Link
EP (1) EP0858466A1 (fr)
JP (1) JPH11514881A (fr)
KR (1) KR19990067174A (fr)
AU (1) AU730324B2 (fr)
BR (1) BR9611206A (fr)
CA (1) CA2233250A1 (fr)
CZ (1) CZ131598A3 (fr)
FR (1) FR2740344B1 (fr)
HU (1) HUP9900011A3 (fr)
NO (1) NO981822L (fr)
SK (1) SK56198A3 (fr)
WO (1) WO1997016459A1 (fr)
ZA (1) ZA969147B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2754822B1 (fr) * 1996-10-18 1998-11-27 Rhone Poulenc Rorer Sa Polypeptides comprenant des domaines de la proteine gax, impliques dans la repression de transcription et/ou interagissant avec d'autres proteines, acides nucleiques correspondants et leurs utilisations
AU2001289652A1 (en) * 2000-06-28 2002-01-08 Aventis Pharma S.A. Compositions and methods for regulating the cell cycle using a ki gene or polypeptide
KR101164602B1 (ko) 2008-01-09 2012-07-10 주식회사 케이알바이오텍 배큘로바이러스?기반 백신
WO2011055888A1 (fr) 2009-11-06 2011-05-12 Chung-Ang University Industry-Academy Cooperation Foundtion Systèmes de délivrance de gènes à base de nanoparticules
KR101232123B1 (ko) 2010-10-08 2013-02-12 연세대학교 산학협력단 재조합된 유전자발현 조절서열을 가지는 종양 특이적 발현이 개선된 유전자 전달체
WO2013077645A1 (fr) 2011-11-24 2013-05-30 주식회사 바이로메드 Nouvelle lignée cellulaire produisant un adénovirus et son utilisation
KR101429696B1 (ko) 2012-11-21 2014-08-13 국립암센터 안전성 및 항암활성이 증가된 재조합 아데노바이러스 및 이의 용도
CN108289920A (zh) 2015-10-12 2018-07-17 汉阳大学校产学协力团 用于基因转移和基因治疗的腺病毒复合物
US11850215B2 (en) 2017-12-13 2023-12-26 Genemedicine Co., Ltd. Recombinant adenoviruses and stem cells comprising same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2705361B1 (fr) * 1993-05-18 1995-08-04 Centre Nat Rech Scient Vecteurs viraux et utilisation en thérapie génique.
US5856121A (en) * 1994-02-24 1999-01-05 Case Western Reserve University Growth arrest homebox gene
FR2732357B1 (fr) * 1995-03-31 1997-04-30 Rhone Poulenc Rorer Sa Vecteurs viraux et utilisation pour le traitement des desordres hyperproliferatifs, notamment de la restenose

Also Published As

Publication number Publication date
KR19990067174A (ko) 1999-08-16
HUP9900011A3 (en) 1999-11-29
ZA969147B (en) 1997-05-27
BR9611206A (pt) 1999-03-30
FR2740344A1 (fr) 1997-04-30
CA2233250A1 (fr) 1997-05-09
EP0858466A1 (fr) 1998-08-19
SK56198A3 (en) 1998-11-04
AU730324B2 (en) 2001-03-01
CZ131598A3 (cs) 1998-08-12
HUP9900011A2 (hu) 1999-04-28
JPH11514881A (ja) 1999-12-21
NO981822L (no) 1998-04-23
AU7498296A (en) 1997-05-22
WO1997016459A1 (fr) 1997-05-09
FR2740344B1 (fr) 1997-11-21

Similar Documents

Publication Publication Date Title
FI964874A (fi) Vihannesten käsittely
NO971015D0 (no) Forbindelser og metoder for behandling av cancer
NO952573D0 (no) Blandinger for behandling av diabetiske komplikasjoner
NO976063D0 (no) Fremgangsmåte for behandling av diabetes
NO991381D0 (no) Kombinasjonsterapi for behandling av psykoser
LV11615A (lv) Amidi ar arstnieciskam ipasibam
NO991955L (no) FremgangsmÕte for behandling av hydrokarboner
NO982172D0 (no) Anvendelse av epinastin for behandling av smerter
FI971568A (fi) Menetelmä resistenttien kasvainten hoitamiseksi
FI956339A (fi) Hypotalaamisen kuukautisten puuttumisen hoitaminen
ID18679A (id) Penggunaan terapi lanjutan
DE59609662D1 (de) Haarbehandlungsmittel
DE19681419T1 (de) Behandlungssystem
IS4528A (is) Bísýklískar afleiður ísóþíóþvagefnis nothæfar viðlæknismeðferð
NO981822D0 (no) Anvendelse av proteinet GAX for behandling av cancer
EE9700235A (et) Benseenamiidid neurodegeneratiivsete haiguste ravimiseks
NO982582D0 (no) FremgangsmÕte for behandling av smerte
NO982562D0 (no) Sammensetning for behandling av smerte
DE59607418D1 (de) Haarbehandlungsmittel
NO986053D0 (no) Antikonvulsive derivater for behandling av psoriasis
NO20000274D0 (no) Behandling av fluider
NO962812D0 (no) Fremgangsmåte for behandling av nervebetennelse
ID24439A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
NO952526D0 (no) Metoder for behandling av reumatisme
KR970020845U (ko) 근골격계질환 치료보조용 테이프

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application